Home > National Drug Code (NDC) > Placenta Compositum

Placenta Compositum - 50114-7055-1 - (HORSE CHESTNUT and LACTIC ACID, L- and CLAVICEPS PURPUREA SCLEROTIUM and CUPRIC SULFATE and MELILOTUS OFFICINALIS TOP and SUS SCROFA PLACENTA and SOLANUM NIGRUM WHOLE and STROPHANTHUS HISPIDUS SEED and SUS SCROFA EMBRYO and SODIUM PYRUVATE and SUS SCROFA VEIN and SUS SCROFA ARTERY and SUS SCROFA UMBILICAL CORD and TOBACCO LEAF and VIPERA BERUS VENOM and BARIUM CARBONATE and LEAD IODIDE)

Alphabetical Index


Drug Information of Placenta Compositum

Product NDC: 50114-7055
Proprietary Name: Placenta Compositum
Non Proprietary Name: HORSE CHESTNUT and LACTIC ACID, L- and CLAVICEPS PURPUREA SCLEROTIUM and CUPRIC SULFATE and MELILOTUS OFFICINALIS TOP and SUS SCROFA PLACENTA and SOLANUM NIGRUM WHOLE and STROPHANTHUS HISPIDUS SEED and SUS SCROFA EMBRYO and SODIUM PYRUVATE and SUS SCROFA VEIN and SUS SCROFA ARTERY and SUS SCROFA UMBILICAL CORD and TOBACCO LEAF and VIPERA BERUS VENOM and BARIUM CARBONATE and LEAD IODIDE
Active Ingredient(s): 13; 4; 6; 4; 4; 18; 6; 8; 6; 6; 10; 8; 6; 10; 8; 10; 10    [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL & nbsp;   HORSE CHESTNUT and LACTIC ACID, L- and CLAVICEPS PURPUREA SCLEROTIUM and CUPRIC SULFATE and MELILOTUS OFFICINALIS TOP and SUS SCROFA PLACENTA and SOLANUM NIGRUM WHOLE and STROPHANTHUS HISPIDUS SEED and SUS SCROFA EMBRYO and SODIUM PYRUVATE and SUS SCROFA VEIN and SUS SCROFA ARTERY and SUS SCROFA UMBILICAL CORD and TOBACCO LEAF and VIPERA BERUS VENOM and BARIUM CARBONATE and LEAD IODIDE
Administration Route(s): INTRADERMAL; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Dosage Form(s): INJECTION
Coding System: National Drug Codes(NDC)

Labeler Information of Placenta Compositum

Product NDC: 50114-7055
Labeler Name: Heel Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date: 20090430

Package Information of Placenta Compositum

Package NDC: 50114-7055-1
Package Description: 10 VIAL in 1 CARTON (50114-7055-1) > 2.2 mL in 1 VIAL

NDC Information of Placenta Compositum

NDC Code 50114-7055-1
Proprietary Name Placenta Compositum
Package Description 10 VIAL in 1 CARTON (50114-7055-1) > 2.2 mL in 1 VIAL
Product NDC 50114-7055
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name HORSE CHESTNUT and LACTIC ACID, L- and CLAVICEPS PURPUREA SCLEROTIUM and CUPRIC SULFATE and MELILOTUS OFFICINALIS TOP and SUS SCROFA PLACENTA and SOLANUM NIGRUM WHOLE and STROPHANTHUS HISPIDUS SEED and SUS SCROFA EMBRYO and SODIUM PYRUVATE and SUS SCROFA VEIN and SUS SCROFA ARTERY and SUS SCROFA UMBILICAL CORD and TOBACCO LEAF and VIPERA BERUS VENOM and BARIUM CARBONATE and LEAD IODIDE
Dosage Form Name INJECTION
Route Name INTRADERMAL; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Start Marketing Date 20090430
Marketing Category Name UNAPPROVED HOMEOPATHIC
Labeler Name Heel Inc
Substance Name BARIUM CARBONATE; CLAVICEPS PURPUREA SCLEROTIUM; CUPRIC SULFATE; HORSE CHESTNUT; LACTIC ACID, L-; LEAD IODIDE; MELILOTUS OFFICINALIS TOP; SODIUM PYRUVATE; SOLANUM NIGRUM WHOLE; STROPHANTHUS HISPIDUS SEED; SUS SCROFA ARTERY; SUS SCROFA EMBRYO; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; SUS SCROFA VEIN; TOBACCO LEAF; VIPERA BERUS VENOM
Strength Number 13; 4; 6; 4; 4; 18; 6; 8; 6; 6; 10; 8; 6; 10; 8; 10; 10
Strength Unit [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL
Pharmaceutical Classes Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [Chemical/Ingredient],Plant Proteins [Chemical/Ingredient]

Complete Information of Placenta Compositum


General Information